Berkeley Lovelace Jr., NBC News, March 29, 2022 Americans ages 50 and older can now receive a second booster dose of the Pfizer-BioNTech or the Moderna Covid-19 vaccine. Hours after the Food and Drug Administration authorized the second booster on …
Moderna says COVID vaccine for young kids generates strong immune response
Berkeley Lovelace Jr., NBC News, March 23, 2022 Moderna said Wednesday its Covid-19 vaccine generated a strong immune response and was generally well-tolerated in kids ages 6 months up to 6 years. The drugmaker said two 25-microgram doses of the vaccine, a quarter of the …
Omicron symptoms: What we know about illness caused by the new variant
Erika Edwards, NBC News, Dec. 21, 2021 The dizzying speed of omicron’s spread has left Americans questioning much of what they know about Covid-19, especially on the cusp of holiday travel. “This is hitting us at a very inopportune time,” said Dr. …
FDA clears AstraZeneca’s COVID antibody treatment for immunocompromised
Benjamin Ryan, NBC News, Dec 8, 2021 The Food and Drug Administration authorized the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems before they have been exposed to the coronavirus. The FDA issued an emergency …
‘Mix and match’ COVID vaccine boosters are effective, NIH study finds
Denise Chow and Akshay Syal, MD, NBC News, Oct. 13, 2021 A highly anticipated study of “mixing and matching” Covid-19 vaccines found the approach to be safe and effective, although the Moderna and Pfizer-BioNTech vaccines were found to spark stronger immune system …